Neurocrine Biosciences (NBIX) Other non-cash items (2010 - 2026)
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other non-cash items (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.00 Bn | 1,140.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 639.12 Bn | 557.64 Bn | 17.26 Bn |
| 3 | AbbVie | 502.23 Bn | 475.34 Bn | 12.70 Bn |
| 4 | Merck | 375.29 Bn | 329.67 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.99 Bn | 266.98 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.36 Bn | 12.86 Bn |
| 7 | Amgen | 242.24 Bn | 197.64 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.36 Bn | 167.56 Bn | 6.22 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.29 Bn | 9.99 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 300,000.00 |
| Dec 31, 2023 | -900,000.00 |
| Jun 30, 2022 | 70.00 Mn |
| Sep 30, 2011 | -9.24 Mn |
| Sep 30, 2010 | 772,000.00 |
API Access
Neurocrine Biosciences Other non-cash items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-cash-items", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();